Two Merck Medicines Recommended For Approval In The European Union
May 15th 2008Drug InformationCholesterol
Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union (EU). The CHMP recommended marketing approval for TREDAPTIVE? (nicotinic acid/ laropiprant, MSD) 1000 mg/20 mg tablets for patients with dyslipidemia or primary hypercholesterolemia. Separately, the U.S.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
